what are non glp-1 medications for weight loss Understanding Medications: vs. Phentermine Losing the Weight Loss Meds:

Similarly, medical studies report that new GLP-1 prescriptions have become predominantly for obesity rather than diabetes: e.g., in 20192023 only ~57% of new GLP-1 patients had T2D (down from ~65% a decade earlier) ( [27] ) ( [28] )

Neurotherapeutics (2018) 15(1):3659

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus

Furthermore, the majority of our studies involve acute metformin administration and so our data cannot rule out the possibility that signalling through the GLP1R might contribute more substantially to the chronic glucose-lowering actions of metformin in more severe models of hyperglycaemia

Because of the retrospective nature of the study and the use of de-identified data, this study received an exemption waiver for approval and informed consent from the Institutional Review Board (IRB) of Chung Shan Medical University Hospital, identified by the reference number CS1-24047